BR0109915A - Teste de diagnóstico para doença de alzheimer - Google Patents

Teste de diagnóstico para doença de alzheimer

Info

Publication number
BR0109915A
BR0109915A BR0109915-9A BR0109915A BR0109915A BR 0109915 A BR0109915 A BR 0109915A BR 0109915 A BR0109915 A BR 0109915A BR 0109915 A BR0109915 A BR 0109915A
Authority
BR
Brazil
Prior art keywords
disease
alzheimer
diagnostic test
patient
sample
Prior art date
Application number
BR0109915-9A
Other languages
English (en)
Inventor
David Henry Small
Javier Saez-Valero
Original Assignee
Axonyx Inc
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc, Univ Melbourne filed Critical Axonyx Inc
Publication of BR0109915A publication Critical patent/BR0109915A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

"TESTE DE DIAGNóSTICO PARA DOENçA DE ALZHEIMER". A presente invenção refere-se a um método para o diagnóstico de doença de Alzheimer (AD) em um paciente compreendendo as etapas de: (1) provisão de uma amostra de um fluido do corpo apropriado do dito paciente e (2) detecção da presença de BuChE com um padrão de glicosilação alterado na dita amostra.
BR0109915-9A 2000-04-07 2001-04-09 Teste de diagnóstico para doença de alzheimer BR0109915A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19523100P 2000-04-07 2000-04-07
PCT/US2001/011654 WO2001077370A1 (en) 2000-04-07 2001-04-09 Diagnostic test for alzheimer's disease

Publications (1)

Publication Number Publication Date
BR0109915A true BR0109915A (pt) 2003-06-10

Family

ID=22720559

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109915-9A BR0109915A (pt) 2000-04-07 2001-04-09 Teste de diagnóstico para doença de alzheimer

Country Status (6)

Country Link
US (2) US20020022242A1 (pt)
JP (1) JP2003530115A (pt)
AU (1) AU2001259046A1 (pt)
BR (1) BR0109915A (pt)
CA (1) CA2442733A1 (pt)
WO (1) WO2001077370A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003090599A2 (en) * 2002-04-25 2003-11-06 Brainsgate Ltd. Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US20020150878A1 (en) * 2001-01-23 2002-10-17 Small David Henry Method for the diagnosis of Alzheimer's Disease and other prion related disorders
WO2004043218A2 (en) * 2002-11-14 2004-05-27 Brainsgate Ltd. Surgical tools and techniques for stimulation
US7684859B2 (en) * 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
JP2006515927A (ja) * 2002-12-20 2006-06-08 モメンタ ファーマシューティカルズ インコーポレイテッド 疾患を診断および監視するためのグリカンマーカー
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8010189B2 (en) * 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US20090299418A1 (en) * 2004-08-23 2009-12-03 Brainsgate Ltd. Concurrent bilateral spg modulation
US20090210026A1 (en) * 2006-08-17 2009-08-20 Brainsgate Ltd. Spg stimulation for enhancing neurogenesis and brain metabolism
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
ES2889914B2 (es) * 2020-07-01 2022-07-21 Univ Miguel Hernandez De Elche PATRON DE GLICOSILACION DE sAPPalfa Y/O sAPPbeta COMO BIOMARCADOR DIAGNOSTICO DE LA ENFERMEDAD DE ALZHEIMER, METODO Y KIT BASADOS EN EL MISMO

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200324A (en) * 1990-09-04 1993-04-06 E. R. Squibb & Sons, Inc. Method of diagnosing senile dementia of the Alzheimer type

Also Published As

Publication number Publication date
CA2442733A1 (en) 2001-10-18
WO2001077370A1 (en) 2001-10-18
US20020022242A1 (en) 2002-02-21
AU2001259046A1 (en) 2001-10-23
JP2003530115A (ja) 2003-10-14
US20040038377A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
BR0109915A (pt) Teste de diagnóstico para doença de alzheimer
ES2665245T3 (es) Proceso de detección de biomarcador y ensayo de estado neurológico
AR027594A1 (es) Dispositivo para detectar analitos biologicos en desechos corporales o en la piel de un usuario.
PT1381866E (pt) Processo para o diagnostico diferencial da demencia de alzheimer e dispositivo para o mesmo
WO2003075745A3 (en) Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry
EE05675B1 (et) Meetod konformse haiguse diagnoosimiseks v?i tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
WO2004103150A3 (en) Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
BRPI0718106B8 (pt) artigo absorvente selecionado de artigos absorventes de cuidados pessoais e artigos absorventes médicos, para receber urina suspeita de conter um analito
BRPI0720035A2 (pt) métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit
DE50202018D1 (de) Intrakorporale sonde zur analyse oder diagnose und/oder therapie
ATE295203T1 (de) Patientenpositionierungssystem für die radiotherapie
BRPI0500710B8 (pt) artigo absorvente que tem características de mascaramento de mancha
WO2006073682A3 (en) Diagnostic test
BR0108802A (pt) Métodos de diagnóstico e terapêuticos para glaucoma
BR9813015A (pt) Processo para o diagnóstico da doença de alzheimer em um paciente e isoforma anormal de acetilcolinesterase com um padrão de glicosilação alterado
EP1543331A4 (en) PROCESS FOR THE DIAGNOSIS OF MORBUS ALZHEIMER
WO2009014342A3 (en) Markers and kit for diagnosis of alzheimer's disease
ATE145673T1 (de) Verfahren zur diagnostizierung von menschlicher grippe und in position 4 modifizierte chromogene n-acetylneuraminsäure substrate zur verwendung in diesen verfahren
DE60026743D1 (de) Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm-lumenbildgebung
DE602007006284D1 (de) Verfahren zur vorhersage des ansprechens von patienten mit multipler sklerose auf eine interferontherapie und zur diagnose von multipler sklerose
ATE395601T1 (de) Verfahren zum vorhersagen von preeclampsia und anderen krankheiten
DE602006002490D1 (de) Verfahren zur diagnose von tumoren
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
PT1297342E (pt) Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: THE UNIVERSITY OF MELBOURNE (AU)

Free format text: TRANSFERIDO DE: AXONYX, INC.

B25A Requested transfer of rights approved

Owner name: MONASH UNIVERSITY (AU)

Free format text: TRANSFERIDO DE: THE UNIVERSITY OF MELBOURNE

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.